1 Market Overview

1.1 Product Overview and Scope of Prostate Cancer Diagnosis and Treatment

1.2 Classification of Prostate Cancer Diagnosis and Treatment by Type

1.2.1 Overview: Global Prostate Cancer Diagnosis and Treatment Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Type in 2021

1.2.3 Prostate Specific Antigen Test (PSA)

1.2.4 Digital Rectal Exam (DRE)

1.3 Global Prostate Cancer Diagnosis and Treatment Market by Application

1.3.1 Overview: Global Prostate Cancer Diagnosis and Treatment Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospitals

1.3.3 Diagnostic clinics

1.3.4 Research centers

1.4 Global Prostate Cancer Diagnosis and Treatment Market Size & Forecast

1.5 Global Prostate Cancer Diagnosis and Treatment Market Size and Forecast by Region

1.5.1 Global Prostate Cancer Diagnosis and Treatment Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Prostate Cancer Diagnosis and Treatment Market Size by Region, (2017-2022)

1.5.3 North America Prostate Cancer Diagnosis and Treatment Market Size and Prospect (2017-2028)

1.5.4 Europe Prostate Cancer Diagnosis and Treatment Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size and Prospect (2017-2028)

1.5.6 South America Prostate Cancer Diagnosis and Treatment Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Prostate Cancer Diagnosis and Treatment Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Prostate Cancer Diagnosis and Treatment Market Drivers

1.6.2 Prostate Cancer Diagnosis and Treatment Market Restraints

1.6.3 Prostate Cancer Diagnosis and Treatment Trends Analysis

2 Company Profiles

2.1 Abbott Laboratories

2.1.1 Abbott Laboratories Details

2.1.2 Abbott Laboratories Major Business

2.1.3 Abbott Laboratories Prostate Cancer Diagnosis and Treatment Product and Solutions

2.1.4 Abbott Laboratories Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Abbott Laboratories Recent Developments and Future Plans

2.2 AbbVie

2.2.1 AbbVie Details

2.2.2 AbbVie Major Business

2.2.3 AbbVie Prostate Cancer Diagnosis and Treatment Product and Solutions

2.2.4 AbbVie Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 AbbVie Recent Developments and Future Plans

2.3 Active Biotech

2.3.1 Active Biotech Details

2.3.2 Active Biotech Major Business

2.3.3 Active Biotech Prostate Cancer Diagnosis and Treatment Product and Solutions

2.3.4 Active Biotech Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Active Biotech Recent Developments and Future Plans

2.4 Amgen

2.4.1 Amgen Details

2.4.2 Amgen Major Business

2.4.3 Amgen Prostate Cancer Diagnosis and Treatment Product and Solutions

2.4.4 Amgen Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Amgen Recent Developments and Future Plans

2.5 Astellas Pharma

2.5.1 Astellas Pharma Details

2.5.2 Astellas Pharma Major Business

2.5.3 Astellas Pharma Prostate Cancer Diagnosis and Treatment Product and Solutions

2.5.4 Astellas Pharma Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Astellas Pharma Recent Developments and Future Plans

2.6 AstraZeneca

2.6.1 AstraZeneca Details

2.6.2 AstraZeneca Major Business

2.6.3 AstraZeneca Prostate Cancer Diagnosis and Treatment Product and Solutions

2.6.4 AstraZeneca Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 AstraZeneca Recent Developments and Future Plans

2.7 Bavarian Nordic

2.7.1 Bavarian Nordic Details

2.7.2 Bavarian Nordic Major Business

2.7.3 Bavarian Nordic Prostate Cancer Diagnosis and Treatment Product and Solutions

2.7.4 Bavarian Nordic Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Bavarian Nordic Recent Developments and Future Plans

2.8 Bayer

2.8.1 Bayer Details

2.8.2 Bayer Major Business

2.8.3 Bayer Prostate Cancer Diagnosis and Treatment Product and Solutions

2.8.4 Bayer Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Bayer Recent Developments and Future Plans

2.9 Bristol-Myers Squibb

2.9.1 Bristol-Myers Squibb Details

2.9.2 Bristol-Myers Squibb Major Business

2.9.3 Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Product and Solutions

2.9.4 Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Bristol-Myers Squibb Recent Developments and Future Plans

2.10 Dendreon

2.10.1 Dendreon Details

2.10.2 Dendreon Major Business

2.10.3 Dendreon Prostate Cancer Diagnosis and Treatment Product and Solutions

2.10.4 Dendreon Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Dendreon Recent Developments and Future Plans

2.11 Endo

2.11.1 Endo Details

2.11.2 Endo Major Business

2.11.3 Endo Prostate Cancer Diagnosis and Treatment Product and Solutions

2.11.4 Endo Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Endo Recent Developments and Future Plans

2.12 Ferring Pharmaceuticals

2.12.1 Ferring Pharmaceuticals Details

2.12.2 Ferring Pharmaceuticals Major Business

2.12.3 Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Product and Solutions

2.12.4 Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Ferring Pharmaceuticals Recent Developments and Future Plans

2.13 GE Healthcare

2.13.1 GE Healthcare Details

2.13.2 GE Healthcare Major Business

2.13.3 GE Healthcare Prostate Cancer Diagnosis and Treatment Product and Solutions

2.13.4 GE Healthcare Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 GE Healthcare Recent Developments and Future Plans

2.14 GSK

2.14.1 GSK Details

2.14.2 GSK Major Business

2.14.3 GSK Prostate Cancer Diagnosis and Treatment Product and Solutions

2.14.4 GSK Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 GSK Recent Developments and Future Plans

2.15 Ipsen

2.15.1 Ipsen Details

2.15.2 Ipsen Major Business

2.15.3 Ipsen Prostate Cancer Diagnosis and Treatment Product and Solutions

2.15.4 Ipsen Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Ipsen Recent Developments and Future Plans

2.16 Johnson & Johnson

2.16.1 Johnson & Johnson Details

2.16.2 Johnson & Johnson Major Business

2.16.3 Johnson & Johnson Prostate Cancer Diagnosis and Treatment Product and Solutions

2.16.4 Johnson & Johnson Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 Johnson & Johnson Recent Developments and Future Plans

2.17 Pfizer

2.17.1 Pfizer Details

2.17.2 Pfizer Major Business

2.17.3 Pfizer Prostate Cancer Diagnosis and Treatment Product and Solutions

2.17.4 Pfizer Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17.5 Pfizer Recent Developments and Future Plans

2.18 Sanofi

2.18.1 Sanofi Details

2.18.2 Sanofi Major Business

2.18.3 Sanofi Prostate Cancer Diagnosis and Treatment Product and Solutions

2.18.4 Sanofi Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.18.5 Sanofi Recent Developments and Future Plans

2.19 Siemens Healthineers

2.19.1 Siemens Healthineers Details

2.19.2 Siemens Healthineers Major Business

2.19.3 Siemens Healthineers Prostate Cancer Diagnosis and Treatment Product and Solutions

2.19.4 Siemens Healthineers Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.19.5 Siemens Healthineers Recent Developments and Future Plans

2.20 Takeda

2.20.1 Takeda Details

2.20.2 Takeda Major Business

2.20.3 Takeda Prostate Cancer Diagnosis and Treatment Product and Solutions

2.20.4 Takeda Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.20.5 Takeda Recent Developments and Future Plans

2.21 Teva Pharmaceutical

2.21.1 Teva Pharmaceutical Details

2.21.2 Teva Pharmaceutical Major Business

2.21.3 Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Product and Solutions

2.21.4 Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.21.5 Teva Pharmaceutical Recent Developments and Future Plans

2.22 Tolmar Pharmaceuticals

2.22.1 Tolmar Pharmaceuticals Details

2.22.2 Tolmar Pharmaceuticals Major Business

2.22.3 Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Product and Solutions

2.22.4 Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.22.5 Tolmar Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Prostate Cancer Diagnosis and Treatment Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Prostate Cancer Diagnosis and Treatment Players Market Share in 2021

3.2.2 Top 10 Prostate Cancer Diagnosis and Treatment Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Prostate Cancer Diagnosis and Treatment Players Head Office, Products and Services Provided

3.4 Prostate Cancer Diagnosis and Treatment Mergers & Acquisitions

3.5 Prostate Cancer Diagnosis and Treatment New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Prostate Cancer Diagnosis and Treatment Revenue and Market Share by Type (2017-2022)

4.2 Global Prostate Cancer Diagnosis and Treatment Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Application (2017-2022)

5.2 Global Prostate Cancer Diagnosis and Treatment Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Prostate Cancer Diagnosis and Treatment Revenue by Type (2017-2028)

6.2 North America Prostate Cancer Diagnosis and Treatment Revenue by Application (2017-2028)

6.3 North America Prostate Cancer Diagnosis and Treatment Market Size by Country

6.3.1 North America Prostate Cancer Diagnosis and Treatment Revenue by Country (2017-2028)

6.3.2 United States Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2017-2028)

6.3.3 Canada Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2017-2028)

6.3.4 Mexico Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Prostate Cancer Diagnosis and Treatment Revenue by Type (2017-2028)

7.2 Europe Prostate Cancer Diagnosis and Treatment Revenue by Application (2017-2028)

7.3 Europe Prostate Cancer Diagnosis and Treatment Market Size by Country

7.3.1 Europe Prostate Cancer Diagnosis and Treatment Revenue by Country (2017-2028)

7.3.2 Germany Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2017-2028)

7.3.3 France Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2017-2028)

7.3.5 Russia Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2017-2028)

7.3.6 Italy Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue by Type (2017-2028)

8.2 Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue by Application (2017-2028)

8.3 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Region

8.3.1 Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue by Region (2017-2028)

8.3.2 China Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2017-2028)

8.3.3 Japan Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2017-2028)

8.3.4 South Korea Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2017-2028)

8.3.5 India Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2017-2028)

8.3.7 Australia Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Prostate Cancer Diagnosis and Treatment Revenue by Type (2017-2028)

9.2 South America Prostate Cancer Diagnosis and Treatment Revenue by Application (2017-2028)

9.3 South America Prostate Cancer Diagnosis and Treatment Market Size by Country

9.3.1 South America Prostate Cancer Diagnosis and Treatment Revenue by Country (2017-2028)

9.3.2 Brazil Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2017-2028)

9.3.3 Argentina Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Prostate Cancer Diagnosis and Treatment Revenue by Type (2017-2028)

10.2 Middle East & Africa Prostate Cancer Diagnosis and Treatment Revenue by Application (2017-2028)

10.3 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Country

10.3.1 Middle East & Africa Prostate Cancer Diagnosis and Treatment Revenue by Country (2017-2028)

10.3.2 Turkey Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2017-2028)

10.3.4 UAE Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Prostate Cancer Diagnosis and Treatment Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Prostate Cancer Diagnosis and Treatment Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Prostate Cancer Diagnosis and Treatment Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Prostate Cancer Diagnosis and Treatment Revenue (USD Million) by Region (2017-2022)

Table 5. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Region (2023-2028)

Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors

Table 7. Abbott Laboratories Major Business

Table 8. Abbott Laboratories Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 9. Abbott Laboratories Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. AbbVie Corporate Information, Head Office, and Major Competitors

Table 11. AbbVie Major Business

Table 12. AbbVie Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 13. AbbVie Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Active Biotech Corporate Information, Head Office, and Major Competitors

Table 15. Active Biotech Major Business

Table 16. Active Biotech Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 17. Active Biotech Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Amgen Corporate Information, Head Office, and Major Competitors

Table 19. Amgen Major Business

Table 20. Amgen Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 21. Amgen Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Astellas Pharma Corporate Information, Head Office, and Major Competitors

Table 23. Astellas Pharma Major Business

Table 24. Astellas Pharma Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 25. Astellas Pharma Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. AstraZeneca Corporate Information, Head Office, and Major Competitors

Table 27. AstraZeneca Major Business

Table 28. AstraZeneca Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 29. AstraZeneca Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Bavarian Nordic Corporate Information, Head Office, and Major Competitors

Table 31. Bavarian Nordic Major Business

Table 32. Bavarian Nordic Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 33. Bavarian Nordic Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Bayer Corporate Information, Head Office, and Major Competitors

Table 35. Bayer Major Business

Table 36. Bayer Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 37. Bayer Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors

Table 39. Bristol-Myers Squibb Major Business

Table 40. Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 41. Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Dendreon Corporate Information, Head Office, and Major Competitors

Table 43. Dendreon Major Business

Table 44. Dendreon Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 45. Dendreon Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Endo Corporate Information, Head Office, and Major Competitors

Table 47. Endo Major Business

Table 48. Endo Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 49. Endo Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Ferring Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 51. Ferring Pharmaceuticals Major Business

Table 52. Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 53. Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. GE Healthcare Corporate Information, Head Office, and Major Competitors

Table 55. GE Healthcare Major Business

Table 56. GE Healthcare Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 57. GE Healthcare Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. GSK Corporate Information, Head Office, and Major Competitors

Table 59. GSK Major Business

Table 60. GSK Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 61. GSK Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Ipsen Corporate Information, Head Office, and Major Competitors

Table 63. Ipsen Major Business

Table 64. Ipsen Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 65. Ipsen Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 67. Johnson & Johnson Major Business

Table 68. Johnson & Johnson Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 69. Johnson & Johnson Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. Pfizer Corporate Information, Head Office, and Major Competitors

Table 71. Pfizer Major Business

Table 72. Pfizer Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 73. Pfizer Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 74. Sanofi Corporate Information, Head Office, and Major Competitors

Table 75. Sanofi Major Business

Table 76. Sanofi Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 77. Sanofi Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 78. Siemens Healthineers Corporate Information, Head Office, and Major Competitors

Table 79. Siemens Healthineers Major Business

Table 80. Siemens Healthineers Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 81. Siemens Healthineers Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 82. Takeda Corporate Information, Head Office, and Major Competitors

Table 83. Takeda Major Business

Table 84. Takeda Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 85. Takeda Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 86. Teva Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 87. Teva Pharmaceutical Major Business

Table 88. Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 89. Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 90. Tolmar Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 91. Tolmar Pharmaceuticals Major Business

Table 92. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 93. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 94. Global Prostate Cancer Diagnosis and Treatment Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 95. Global Prostate Cancer Diagnosis and Treatment Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 96. Breakdown of Prostate Cancer Diagnosis and Treatment by Company Type (Tier 1, Tier 2 and Tier 3)

Table 97. Prostate Cancer Diagnosis and Treatment Players Head Office, Products and Services Provided

Table 98. Prostate Cancer Diagnosis and Treatment Mergers & Acquisitions in the Past Five Years

Table 99. Prostate Cancer Diagnosis and Treatment New Entrants and Expansion Plans

Table 100. Global Prostate Cancer Diagnosis and Treatment Revenue (USD Million) by Type (2017-2022)

Table 101. Global Prostate Cancer Diagnosis and Treatment Revenue Share by Type (2017-2022)

Table 102. Global Prostate Cancer Diagnosis and Treatment Revenue Forecast by Type (2023-2028)

Table 103. Global Prostate Cancer Diagnosis and Treatment Revenue by Application (2017-2022)

Table 104. Global Prostate Cancer Diagnosis and Treatment Revenue Forecast by Application (2023-2028)

Table 105. North America Prostate Cancer Diagnosis and Treatment Revenue by Type (2017-2022) & (USD Million)

Table 106. North America Prostate Cancer Diagnosis and Treatment Revenue by Type (2023-2028) & (USD Million)

Table 107. North America Prostate Cancer Diagnosis and Treatment Revenue by Application (2017-2022) & (USD Million)

Table 108. North America Prostate Cancer Diagnosis and Treatment Revenue by Application (2023-2028) & (USD Million)

Table 109. North America Prostate Cancer Diagnosis and Treatment Revenue by Country (2017-2022) & (USD Million)

Table 110. North America Prostate Cancer Diagnosis and Treatment Revenue by Country (2023-2028) & (USD Million)

Table 111. Europe Prostate Cancer Diagnosis and Treatment Revenue by Type (2017-2022) & (USD Million)

Table 112. Europe Prostate Cancer Diagnosis and Treatment Revenue by Type (2023-2028) & (USD Million)

Table 113. Europe Prostate Cancer Diagnosis and Treatment Revenue by Application (2017-2022) & (USD Million)

Table 114. Europe Prostate Cancer Diagnosis and Treatment Revenue by Application (2023-2028) & (USD Million)

Table 115. Europe Prostate Cancer Diagnosis and Treatment Revenue by Country (2017-2022) & (USD Million)

Table 116. Europe Prostate Cancer Diagnosis and Treatment Revenue by Country (2023-2028) & (USD Million)

Table 117. Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue by Type (2017-2022) & (USD Million)

Table 118. Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue by Type (2023-2028) & (USD Million)

Table 119. Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue by Application (2017-2022) & (USD Million)

Table 120. Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue by Application (2023-2028) & (USD Million)

Table 121. Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue by Region (2017-2022) & (USD Million)

Table 122. Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue by Region (2023-2028) & (USD Million)

Table 123. South America Prostate Cancer Diagnosis and Treatment Revenue by Type (2017-2022) & (USD Million)

Table 124. South America Prostate Cancer Diagnosis and Treatment Revenue by Type (2023-2028) & (USD Million)

Table 125. South America Prostate Cancer Diagnosis and Treatment Revenue by Application (2017-2022) & (USD Million)

Table 126. South America Prostate Cancer Diagnosis and Treatment Revenue by Application (2023-2028) & (USD Million)

Table 127. South America Prostate Cancer Diagnosis and Treatment Revenue by Country (2017-2022) & (USD Million)

Table 128. South America Prostate Cancer Diagnosis and Treatment Revenue by Country (2023-2028) & (USD Million)

Table 129. Middle East & Africa Prostate Cancer Diagnosis and Treatment Revenue by Type (2017-2022) & (USD Million)

Table 130. Middle East & Africa Prostate Cancer Diagnosis and Treatment Revenue by Type (2023-2028) & (USD Million)

Table 131. Middle East & Africa Prostate Cancer Diagnosis and Treatment Revenue by Application (2017-2022) & (USD Million)

Table 132. Middle East & Africa Prostate Cancer Diagnosis and Treatment Revenue by Application (2023-2028) & (USD Million)

Table 133. Middle East & Africa Prostate Cancer Diagnosis and Treatment Revenue by Country (2017-2022) & (USD Million)

Table 134. Middle East & Africa Prostate Cancer Diagnosis and Treatment Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Prostate Cancer Diagnosis and Treatment Picture

Figure 2. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Type in 2021

Figure 3. Prostate Specific Antigen Test (PSA)

Figure 4. Digital Rectal Exam (DRE)

Figure 5. Prostate Cancer Diagnosis and Treatment Revenue Market Share by Application in 2021

Figure 6. Hospitals Picture

Figure 7. Diagnostic clinics Picture

Figure 8. Research centers Picture

Figure 9. Global Prostate Cancer Diagnosis and Treatment Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 10. Global Prostate Cancer Diagnosis and Treatment Revenue and Forecast (2017-2028) & (USD Million)

Figure 11. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Region (2017-2028)

Figure 12. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Region in 2021

Figure 13. North America Prostate Cancer Diagnosis and Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 14. Europe Prostate Cancer Diagnosis and Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. South America Prostate Cancer Diagnosis and Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Prostate Cancer Diagnosis and Treatment Market Drivers

Figure 19. Prostate Cancer Diagnosis and Treatment Market Restraints

Figure 20. Prostate Cancer Diagnosis and Treatment Market Trends

Figure 21. Abbott Laboratories Recent Developments and Future Plans

Figure 22. AbbVie Recent Developments and Future Plans

Figure 23. Active Biotech Recent Developments and Future Plans

Figure 24. Amgen Recent Developments and Future Plans

Figure 25. Astellas Pharma Recent Developments and Future Plans

Figure 26. AstraZeneca Recent Developments and Future Plans

Figure 27. Bavarian Nordic Recent Developments and Future Plans

Figure 28. Bayer Recent Developments and Future Plans

Figure 29. Bristol-Myers Squibb Recent Developments and Future Plans

Figure 30. Dendreon Recent Developments and Future Plans

Figure 31. Endo Recent Developments and Future Plans

Figure 32. Ferring Pharmaceuticals Recent Developments and Future Plans

Figure 33. GE Healthcare Recent Developments and Future Plans

Figure 34. GSK Recent Developments and Future Plans

Figure 35. Ipsen Recent Developments and Future Plans

Figure 36. Johnson & Johnson Recent Developments and Future Plans

Figure 37. Pfizer Recent Developments and Future Plans

Figure 38. Sanofi Recent Developments and Future Plans

Figure 39. Siemens Healthineers Recent Developments and Future Plans

Figure 40. Takeda Recent Developments and Future Plans

Figure 41. Teva Pharmaceutical Recent Developments and Future Plans

Figure 42. Tolmar Pharmaceuticals Recent Developments and Future Plans

Figure 43. Global Prostate Cancer Diagnosis and Treatment Revenue Share by Players in 2021

Figure 44. Prostate Cancer Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 45. Global Top 3 Players Prostate Cancer Diagnosis and Treatment Revenue Market Share in 2021

Figure 46. Global Top 10 Players Prostate Cancer Diagnosis and Treatment Revenue Market Share in 2021

Figure 47. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 48. Global Prostate Cancer Diagnosis and Treatment Revenue Share by Type in 2021

Figure 49. Global Prostate Cancer Diagnosis and Treatment Market Share Forecast by Type (2023-2028)

Figure 50. Global Prostate Cancer Diagnosis and Treatment Revenue Share by Application in 2021

Figure 51. Global Prostate Cancer Diagnosis and Treatment Market Share Forecast by Application (2023-2028)

Figure 52. North America Prostate Cancer Diagnosis and Treatment Sales Market Share by Type (2017-2028)

Figure 53. North America Prostate Cancer Diagnosis and Treatment Sales Market Share by Application (2017-2028)

Figure 54. North America Prostate Cancer Diagnosis and Treatment Revenue Market Share by Country (2017-2028)

Figure 55. United States Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Canada Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Mexico Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Europe Prostate Cancer Diagnosis and Treatment Sales Market Share by Type (2017-2028)

Figure 59. Europe Prostate Cancer Diagnosis and Treatment Sales Market Share by Application (2017-2028)

Figure 60. Europe Prostate Cancer Diagnosis and Treatment Revenue Market Share by Country (2017-2028)

Figure 61. Germany Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. France Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. United Kingdom Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Russia Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Italy Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Asia-Pacific Prostate Cancer Diagnosis and Treatment Sales Market Share by Type (2017-2028)

Figure 67. Asia-Pacific Prostate Cancer Diagnosis and Treatment Sales Market Share by Application (2017-2028)

Figure 68. Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue Market Share by Region (2017-2028)

Figure 69. China Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Japan Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. South Korea Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. India Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Southeast Asia Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Australia Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. South America Prostate Cancer Diagnosis and Treatment Sales Market Share by Type (2017-2028)

Figure 76. South America Prostate Cancer Diagnosis and Treatment Sales Market Share by Application (2017-2028)

Figure 77. South America Prostate Cancer Diagnosis and Treatment Revenue Market Share by Country (2017-2028)

Figure 78. Brazil Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. Argentina Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. Middle East and Africa Prostate Cancer Diagnosis and Treatment Sales Market Share by Type (2017-2028)

Figure 81. Middle East and Africa Prostate Cancer Diagnosis and Treatment Sales Market Share by Application (2017-2028)

Figure 82. Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue Market Share by Country (2017-2028)

Figure 83. Turkey Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 84. Saudi Arabia Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 85. UAE Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 86. Methodology

Figure 87. Research Process and Data Source